drugset / Trial / NCT00629642
Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A clinical study to evaluate the efficacy and safety of solifenacin in patients with bladder symptoms due to spinal cord injury or multiple sclerosis
Timeline
- Start
- 2008-03-14
- Primary completion
- 2011-01-28
- Completion
- 2011-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxybutynin | Small molecule | 5 mg | Oral |
| Subject | Solifenacin | Small molecule | 5 mg | Oral |
| Subject | Solifenacin | Small molecule | 10 mg | Oral |